跳到正文
Oriol Mirallas MD· @DrMirallas · X·· 2026-04-20评分60
正文 · 原文

#AACR26

Dual Payload #ADC by
@AstraZeneca

MMAE DAR 2 + TOPI DAR 8 against #CD30
nnAA
Increased potency

New and more potent #ADC being developed and hopefully soon in the #phaseI trials

#oncology
@AACR

@OncoAlert

热度 42 · 25 赞 · 2 回复 · 15 转发

来源:Oriol Mirallas MD · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org